RM Secured C (LSE:RMDC)
Historical Stock Chart
From Oct 2019 to Oct 2024
Boston Scientific Completes Acquisition of Rubicon Medical
Corporation
NATICK, Mass., June 15 /PRNewswire-FirstCall/ -- Boston Scientific Corporation
(NYSE:BSX) today announced that it has completed the final phase of its
acquisition of Rubicon Medical Corporation (OTC:RMDC) (BULLETIN BOARD: RMDC) .
Boston Scientific previously completed a cash tender offer for any and all
outstanding common stock of Rubicon on June 1, 2005. The tender offer was
followed by the merger of Nemo I Acquisition, Inc., a wholly-owned subsidiary
of Boston Scientific, with and into Rubicon on June 14, 2005. Following the
merger, Rubicon became a wholly-owned subsidiary of Boston Scientific.
About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of
medical devices whose products are used in a broad range of interventional
medical specialties. For more information, please visit:
http://www.bostonscientific.com/.
About Rubicon Medical
Rubicon Medical Corporation (http://www.rubiconmed.com/) is a Salt Lake
City-based developer and manufacturer of interventional vascular medical
devices and products.
CONTACT:
Milan Kofol
508-650-8569
Investor Relations
Boston Scientific Corporation
Paul Donovan
508-650-8541
Media Relations
Boston Scientific Corporation
DATASOURCE: Boston Scientific Corporation
CONTACT: Milan Kofol, Investor Relations, +1-508-650-8569, or Paul
Donovan, Media Relations, +1-508-650-8541, both of Boston Scientific
Corporation
Web site: http://www.bostonscientific.com/
http://www.rubiconmed.com/